Table 2.
Sociodemographic, clinical, and psychosocial characteristics of the included AYA survivors.
| Population Characteristics | Total Included AYA Survivors 1 | AYA Survivors with a Negative Body Image |
AYA Survivors without a Negative Body Image |
Missing | ||||
|---|---|---|---|---|---|---|---|---|
| n = 3735 | n = 541 | n = 3194 | ||||||
| n | % | n | % | n | % | n | ||
| Sociodemographic characteristics | ||||||||
| Age at questionnaire—Mean (SD) | 44.5 (7.5) | 44.2 (7.3) | 44.6 (7.5) | |||||
| Gender | Male | 1456 | 39.0 | 94 | 6.5 | 1362 | 93.5 | |
| Female | 2279 | 61.0 | 447 | 19.6 | 1832 | 80.4 | ||
| Partner (yes) | 3107 | 83.4 | 395 | 12.7 | 2710 | 87.3 | 13 | |
| Level of education | Low | 24 | 0.6 | 6 | 25.0 | 18 | 75.0 | 8 |
| Intermediate | 1601 | 42.9 | 277 | 17.3 | 1322 | 82.7 | ||
| High | 2106 | 56.4 | 257 | 12.2 | 1847 | 87.8 | ||
| Clinical characteristics | ||||||||
| Type of Cancer | Melanoma | 258 | 6.9 | 18 | 7.0 | 240 | 93.0 | |
| Head and neck | 115 | 3.1 | 12 | 10.4 | 103 | 89.6 | ||
| Colon and rectal | 76 | 2.0 | 8 | 10.5 | 68 | 89.5 | ||
| Digestive tract other 2 | 30 | 0.8 | 6 | 20.0 | 24 | 80.0 | ||
| Breast | 885 | 23.7 | 191 | 21.6 | 694 | 78.4 | ||
| Female genitalia | 407 | 10.9 | 92 | 22.6 | 315 | 77.4 | ||
| Thyroid gland | 228 | 6.1 | 26 | 11.4 | 202 | 88.6 | ||
| Central nervous system | 142 | 3.8 | 22 | 15.5 | 120 | 84.5 | ||
| Bone and soft tissue sarcoma | 165 | 4.4 | 20 | 12.1 | 145 | 87.9 | ||
| Germ cell tumor | 653 | 17.5 | 38 | 5.8 | 615 | 94.2 | ||
| Lymphoid hematological malignancies | 555 | 14.9 | 76 | 13.7 | 479 | 86.3 | ||
| Myeloid hematological malignancies | 140 | 3.7 | 21 | 15.0 | 119 | 85.0 | ||
| Other 3 | 81 | 2.2 | 11 | 13.6 | 70 | 86.4 | ||
| Treatments 4 | Surgery organ (yes) | 2483 | 66.6 | 368 | 14.8 | 2115 | 85.2 | 4 |
| Surgery local (yes) | 537 | 14.4 | 69 | 12.8 | 468 | 87.2 | 4 | |
| Chemotherapy (yes) | 2104 | 56.4 | 342 | 16.3 | 1762 | 83.7 | 4 | |
| Radiotherapy (yes) 5 | 1779 | 47.7 | 299 | 16.8 | 1480 | 83.2 | 4 | |
| Hormone therapy (yes) | 455 | 12.2 | 113 | 24.8 | 342 | 75.2 | 4 | |
| Targeted therapy (yes) | 289 | 7.7 | 53 | 18.3 | 236 | 81.7 | 4 | |
| Stem cell transplantation (yes) | 135 | 3.6 | 15 | 11.1 | 120 | 88.9 | 4 | |
| Tumor stage | I | 1595 | 42.7 | 190 | 11.9 | 1405 | 88.1 | |
| II | 991 | 26.5 | 174 | 17.6 | 817 | 82.4 | ||
| III | 535 | 14.3 | 87 | 16.3 | 448 | 83.7 | ||
| IV | 171 | 4.6 | 28 | 16.4 | 143 | 83.6 | ||
| Unknown | 443 | 11.9 | 62 | 14.0 | 381 | 86.0 | ||
| Age at diagnosis—Mean (SD) | 31.6 (5.9) | 31.9 (5.8) | 31.5 (5.9) | |||||
| Time since diagnosis—Mean (SD) | 12.4 (4.5) | 11.8 (4.5) | 12.6 (4.5) | |||||
| <10 years | 1274 | 34.1 | 223 | 17.5 | 1051 | 82.5 | ||
| 10–15 years | 1307 | 35.0 | 171 | 13.1 | 1136 | 86.9 | ||
| >15 years | 1154 | 30.9 | 147 | 12.7 | 1007 | 87.3 | ||
| Physical activity | Time in hours/week—Mean (SD) | 27.9 (25.2) | 30.1 (26.3) | 27.5 (24.8) | 20 | |||
| In MET hours/week—Mean (SD) | 108.6 (92.3) | 114.1 (96.5) | 107.6 (91.4) | |||||
| BMI—Mean (SD) | 25.2 (4.4) | 26.9 (5.9) | 24.9 (4.0) | 24 | ||||
| Underweight | 58 | 1.6 | 11 | 19.0 | 47 | 81.0 | ||
| Normal weight | 2004 | 53.9 | 224 | 11.2 | 1777 | 88.8 | ||
| Overweight | 1218 | 32.8 | 167 | 13.7 | 1050 | 86.3 | ||
| Obesity | 435 | 11.7 | 136 | 31.3 | 299 | 68.7 | ||
| Psychosocial characteristics | ||||||||
| Coping style | Adaptive—Mean (SD) | 29.3 (7.4) | 30.0 (7.1) | 29.1 (7.5) | 45 | |||
| Maladaptive—Mean (SD) | 13.7 (3.8) | 15.7 (4.6) | 12.8 (3.5) | 31 | ||||
| HRQoL | Physical functioning—Mean (SD) | 91.5 (14.0) | 80.5 (18.8) | 93.3 (12.1) | 2 | |||
| Role functioning—Mean (SD) | 83.2 (25.4) | 59.7 (32.1) | 87.2 (21.7) | 6 | ||||
| Emotional functioning—Mean (SD) | 79.5 (20.6) | 57.9 (24.1) | 83.1 (17.5) | 2 | ||||
| Cognitive functioning—Mean (SD) | 77.9 (24.4) | 57.7 (28.5) | 81.3 (21.9) | 5 | ||||
| Social functioning—Mean (SD) | 87.9 (22.0) | 66.3 (31.1) | 91.6 (17.7) | 13 | ||||
| Global health status—Mean (SD) | 75.2 (17.5) | 59.2 (19.8) | 77.9 (15.6) | 14 | ||||
| Sexual attractiveness (yes) | 2704 | 72.7 | 497 | 18.4 | 2203 | 81.6 | 18 | |
1 Included AYA survivors completed at least half of the ten items on body image. 2 Digestive tract and other includes the esophagus, stomach, and small intestine. 3 Other includes respiratory, male genitalia (penis, prostate), urinary tract, tumor with other localizations, endocrine glands, eye, neuroblastoma, paraganglioma. 4 The treatments were received at primary diagnosis. 5 Radiotherapy includes radiotherapy for primary tumor and metastases at primary diagnosis. n = number of AYA survivors, Mean (SD) = mean and standard deviation.